Chasseneuil-du-Poitou, France

Christian Berrier


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Christian Berrier

Introduction: Christian Berrier is a notable inventor based in Chasseneuil-du-Poitou, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts at Pierre Fabre Medicament. With one patent to his name, Berrier is recognized for his work on antimitotic binary alkaloid derivatives derived from Catharanthus roseus.

Latest Patents: Christian Berrier's most recent patent focuses on "Antimitotic binary alkaloid derivatives from Catharanthus roseus." This patent contributes to the ongoing research and development of novel treatments in the field of oncology, showcasing Berrier's dedication to addressing critical health challenges.

Career Highlights: Throughout his career at Pierre Fabre Medicament, Christian Berrier has gained valuable experience and expertise in pharmaceutical development. His work not only contributes to the company's innovative product line but also aids in expanding the understanding of medicinal properties derived from natural sources.

Collaborations: Berrier has had the opportunity to collaborate with esteemed colleagues such as Jean-Claude Jacquesy and Jacques Fahy. These collaborations enhance the breadth of knowledge and innovation within the team at Pierre Fabre Medicament, leading to significant advancements in their research endeavors.

Conclusion: Christian Berrier stands out as a dedicated inventor whose work is making an impact in the field of pharmaceuticals. With his focus on antimitotic binary alkaloid derivatives, he is contributing to advancements in cancer treatments. His collaborations and role at Pierre Fabre Medicament further solidify his importance in the innovation landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…